The role of Sodium-Glucose Transporter-2 Inhibitors (SGLT-2i) in preventing chronic obstructive disease exacerbation in patients with diabetes and COPD: An electronic health database analysis.

MLA

Gupta, Sushan, et al. “The Role of Sodium-Glucose Transporter-2 Inhibitors (SGLT-2i) in Preventing Chronic Obstructive Disease Exacerbation in Patients with Diabetes and COPD: An Electronic Health Database Analysis.” Heart & Lung, vol. 68, Nov. 2024, pp. 191–94. EBSCOhost, https://doi.org/10.1016/j.hrtlng.2024.07.003.

APA

Gupta, S., Mohta, A., Lauinger, A., & Thameem, D. (2024). The role of Sodium-Glucose Transporter-2 Inhibitors (SGLT-2i) in preventing chronic obstructive disease exacerbation in patients with diabetes and COPD: An electronic health database analysis. Heart & Lung, 68, 191–194. https://doi.org/10.1016/j.hrtlng.2024.07.003

Chicago

Gupta, Sushan, Avani Mohta, Alexa Lauinger, and Danish Thameem. 2024. “The Role of Sodium-Glucose Transporter-2 Inhibitors (SGLT-2i) in Preventing Chronic Obstructive Disease Exacerbation in Patients with Diabetes and COPD: An Electronic Health Database Analysis.” Heart & Lung 68 (November): 191–94. doi:10.1016/j.hrtlng.2024.07.003.